Literature DB >> 27247049

Expanding the clinical picture of the MECP2 Duplication syndrome.

Z Lim1, J Downs1,2, K Wong1, C Ellaway3,4,5, H Leonard1.   

Abstract

Individuals with two or more copies of the MECP2 gene, located at Xq28, share clinical features and a distinct facial phenotype known as MECP2 Duplication syndrome. We have examined perinatal characteristics, early childhood development and medical co-morbidities in this disorder. The International Rett Syndrome Phenotype Database (InterRett), which collects information from caregivers and clinicians on individuals with Rett syndrome and MECP2 associated disorders, was used as the data source. Data were available on 56 cases (49 males and 7 females) with MECP2 Duplication syndrome. Median age at ascertainment was 7.9 years (range: 1.2-37.6 years) and at diagnosis 3.0 years (range: 3 weeks-37 years). Less than a third (29%) learned to walk. Speech deterioration was reported in 34% and only 20% used word approximations or better at ascertainment. Over half (55%) had been hospitalised for respiratory infections in the first 2 years of life. Just under half (44%) had seizures, occurring daily in nearly half of this group. The majority (89%) had gastrointestinal problems and a third had a gastrostomy. Following the recent demonstration of phenotype reversal in a mouse model of MECP2 Duplication, a clear understanding of the natural history is crucial to the design and implementation of future therapeutic strategies.
© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  MECP2 Duplication; intellectual disability; international database; natural history; phenotype; rare disorder

Mesh:

Substances:

Year:  2016        PMID: 27247049     DOI: 10.1111/cge.12814

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  19 in total

Review 1.  Cyclin-Dependent Kinase-Like 5 Deficiency Disorder: Clinical Review.

Authors:  Heather E Olson; Scott T Demarest; Elia M Pestana-Knight; Lindsay C Swanson; Sumaiya Iqbal; Dennis Lal; Helen Leonard; J Helen Cross; Orrin Devinsky; Tim A Benke
Journal:  Pediatr Neurol       Date:  2019-02-23       Impact factor: 3.372

Review 2.  Clinical and biological progress over 50 years in Rett syndrome.

Authors:  Helen Leonard; Stuart Cobb; Jenny Downs
Journal:  Nat Rev Neurol       Date:  2016-12-09       Impact factor: 42.937

3.  Characterizing the phenotypic effect of Xq28 duplication size in MECP2 duplication syndrome.

Authors:  Sarika U Peters; Cary Fu; Bernhard Suter; Eric Marsh; Timothy A Benke; Steve A Skinner; David N Lieberman; Shannon Standridge; Mary Jones; Arthur Beisang; Timothy Feyma; Peter Heydeman; Robin Ryther; Walter E Kaufmann; Daniel G Glaze; Jeffrey L Neul; Alan K Percy
Journal:  Clin Genet       Date:  2019-03-15       Impact factor: 4.438

Review 4.  X-linked intellectual disability update 2017.

Authors:  Giovanni Neri; Charles E Schwartz; Herbert A Lubs; Roger E Stevenson
Journal:  Am J Med Genet A       Date:  2018-04-25       Impact factor: 2.802

5.  Intellectual disability and epilepsy due to the K/L-mediated Xq28 duplication: Further evidence of a distinct, dosage-dependent phenotype.

Authors:  David Isum Ward; Bethany A Buckley; Eyby Leon; Jullianne Diaz; Margaret Faust Galegos; Sean Hofherr; Amy Feldman Lewanda
Journal:  Am J Med Genet A       Date:  2018-01-17       Impact factor: 2.802

6.  Spectrum and time course of epilepsy and the associated cognitive decline in MECP2 duplication syndrome.

Authors:  Dana Marafi; Bernhard Suter; Rebecca Schultz; Daniel Glaze; Valory N Pavlik; Alica M Goldman
Journal:  Neurology       Date:  2018-12-14       Impact factor: 9.910

7.  Engineered microRNA-based regulatory element permits safe high-dose miniMECP2 gene therapy in Rett mice.

Authors:  Sarah E Sinnett; Emily Boyle; Christopher Lyons; Steven J Gray
Journal:  Brain       Date:  2021-11-29       Impact factor: 13.501

8.  Comparison of Core Features in Four Developmental Encephalopathies in the Rett Natural History Study.

Authors:  Clare Cutri-French; Dallas Armstrong; Joni Saby; Casey Gorman; Jane Lane; Cary Fu; Sarika U Peters; Alan Percy; Jeffrey L Neul; Eric D Marsh
Journal:  Ann Neurol       Date:  2020-06-29       Impact factor: 10.422

9.  Clinical and molecular genetic characterization of familial MECP2 duplication syndrome in a Chinese family.

Authors:  Xiaoyan Li; Hua Xie; Qian Chen; Xiongying Yu; Zhaoshi Yi; Erzhen Li; Ting Zhang; Jian Wang; Jianmin Zhong; Xiaoli Chen
Journal:  BMC Med Genet       Date:  2017-11-15       Impact factor: 2.103

10.  Phenotypic features in MECP2 duplication syndrome: Effects of age.

Authors:  Sarika U Peters; Cary Fu; Eric D Marsh; Tim A Benke; Bernard Suter; Steve A Skinner; David N Lieberman; Shannon Standridge; Mary Jones; Arthur Beisang; Timothy Feyma; Peter Heydeman; Robin Ryther; Daniel G Glaze; Alan K Percy; Jeffrey L Neul
Journal:  Am J Med Genet A       Date:  2020-11-10       Impact factor: 2.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.